NE

New Enterprise Associates

Editorial Pick Active

Researched and published by the startup.ph editorial team from public sources — not a self-submitted profile.

New Enterprise Associates (NEA)

VC Fund 📍 United States, North America

About New Enterprise Associates

New Enterprise Associates (NEA) is one of the world's largest venture capital firms, founded in 1977 by C. Richard Kramlich, Charles Newhall III, and Frank Bonsal Jr. It is headquartered in Menlo Park, California, with additional U.S. offices in Timonium, Maryland and New York City, and an international presence spanning London, Mumbai, Bangalore, Beijing, and Shanghai. The firm is currently led by Scott Sandell as Executive Chairman, with Tony Florence and Mohamad Makhzoumi as Co-CEOs.

NEA manages approximately $25 billion in committed capital as of 2023. Its funds have grown from an initial $16 million to its sixteenth fund, which closed at $3.3 billion in 2017. Since its founding, NEA has backed nearly 1,000 companies across technology and healthcare, generating over 650 liquidity events including more than 250 IPOs and 300+ acquisitions. Recent notable investments include Databricks, Acadia Pharmaceuticals, Amicus Therapeutics, Clovis Oncology, and Tesaro. No Philippines-specific investment activity was confirmed from available sources, though NEA does have an active China and India presence.

Investment Thesis

NEA invests across the full lifecycle from early venture through growth stage, concentrated in technology and healthcare/life sciences, using a large committed capital base and multi-decade track record to back both first-time founders and established companies scaling toward IPO or acquisition. Its global office network (including India and China) supports direct sourcing and support outside the U.S. as well.

Portfolio Companies

Databricks, Acadia Pharmaceuticals, Amicus Therapeutics, Clovis Oncology, Tesaro